Journals / Turkish Journal of Obstetrics and Gynecology / 2020 / Cilt: 17 - Sayı: 4

Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases

Hipogonadotropik hipogonadizm hastalarında ciddi ovaryan hiperstimülasyon sendromu ve gonadotropin releasing hormon agonistiyle trigger: İki olgu sunumu

Pages
90–93
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If a GnRH stimulation test is performed before ovarian stimulation, OHSS can be prevented because the test allows agonist triggering instead of hCG in hypogonadotropic hypogonadism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ovarian Hyperstimulation syndrome (OHSS) is a rare condition in patients with hypogonadotropic hypogonadism.
📊
Key Findings & Data:The first case was a 31-year-old patient.
💡
Conclusion & Impact:If a GnRH stimulation test is performed before ovarian stimulation, OHSS can be prevented because the test allows agonist triggering instead of hCG in hypogonadotropic hypogonadism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ovarian Hyperstimulation syndrome (OHSS) is a rare condition in patients with hypogonadotropic hypogonadism. Two patients with hypogonadotropic hypogonadism are reported, a rare case of severe OHSS and a case of prevented OHSS via gonadotropin-releasing hormone (GnRH) agonist trigger, respectively. The first case was a 31-year-old patient. In vitro fertilization (IVF) treatment was performed three times but the patient never developed OHSS. The first patient was diagnosed as having severe OHSS on the ninth day after the fresh embryo transfer. She stayed 66 days in hospital and 50.5 litres of fluid were aspirated from her abdomen. The second case was a 26-year-old and primary infertile patient. She had never undergone IVF treatment. The GnRH agonist stimulation test was performed before IVF treatment. After the ovarian stimulation, GnRH agonist trigger was given. Thirty-two oocytes were retrieved from the ovaries and OHSS did not occur. Although severe OHSS is rare, it can develop in patients hypogonadotropic hypogonadism. If a GnRH stimulation test is performed before ovarian stimulation, OHSS can be prevented because the test allows agonist triggering instead of hCG in hypogonadotropic hypogonadism.

Özet

Over Hiperstimülasyon sendromu (OHSS) hipogonadotropik hipogonadizm hastalarında nadirdir. Burada ciddi OHSS olgusu ve gonadotropin salgılatıcı hormon (GnRH) agonist triggeriyle OHSS engellenmiş hipogonadotropik hipogonadizmi olan iki hasta sunulmuştur. İlk olgu 31 yaşında bir hastaydı. Üç kez in vitro fertilizasyon (IVF) tedavisi uygulanmış ancak olguda over hiperstimülasyon sendromu hiç gelişmemiş. Taze embriyo transferinden sonraki dokuzuncu günde şiddetli OHSS tanısı konuldu. Hastanede 66 gün kaldı ve batından 50,5 litre asit sıvısı aspire edildi. İkinci olgu 26 yaşında ve primer infertil hastaydı. Hiç IVF tedavisi görmemişti. IVF tedavisinden önce GnRH agonist stimülasyon testi uygulandı. Ovaryan stimülasyondan sonra GnRH agonist triggeri yapıldı. Toplanan 32 oosite rağmen OHSS meydana gelmemiştir. Hipogonadotropik hipogonadizm hastalarında şiddetli OHSS nadir olmakla birlikte gelişebilir. Eğer hipogonadotropik hipogonadizm hastalarında ovülasyon indüksiyonundan önce GnRH stimülasyon testi yapılırsa, hCG yerine GnRH agonist trigger yapılabilir ve OHSS önlenebilir.

🔖

Cite This Article

DEVEER, R., GÜRBÜZ, A. S., GÖDE, F., KILIÇ, F., GÜRBÜZ, Z. U. (2022). Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases. Turkish Journal of Obstetrics and Gynecology, Cilt: 17 - Sayı: 4, 90–93. https://ajindex.com/articles/612956

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo) 2013;68(Suppl 1):81- 8
  2. Yildirim G, Ficicioglu C, Attar R, Akcin O, Tecellioglu N. Comparision of reproductive outcome of the women with hypogonadotropic hypogonadism and tubal factor infertility. Clin Exp Obstet Gynecol 2010;37:120-2
  3. Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 2010;94:389-400
  4. Devroey P, Polyzos NP, Bockell C. An OHSS-free clinic by segmentation of IVF treatment. Hum Reprod 2011;26:2593-7
  5. Gao Y, Yu B, Mao J, Wang X, Nie M, Wu X. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis. BMC Endocr Disord 2018;18:85
  6. Engmann L, Benadiva C, Humaidan P. GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reprod Biomed Online 2016;32:274-85
  7. Yilmaz S, Ozgu-Erdinc AS, Yumusak O, Kahyaoglu S, Seckin B, Yilmaz N. The reproductive outcome of women with hypogonadotropic hypogonadism undergoing in vitro fertilization. Syst Biol Reprod Med 2015;61:228-32
  8. Tran ND, Cedars MI, Rosen MP. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab 2011;96:3609-14
  9. Pandurangi M, Tamizharasi M, Reddy NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci 2015;8:146- 50
  10. Levy T, Orvieto R, Homburg R, Peleg D, Dekel A, Ben-Rafael Z. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod 1996;11:1177-9
  11. Ulug U, Ben-Shlomo I, Tosun S, Erden HF, Akman MA, Bahceci M. The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro fertilization and embryo transfer program. J Assist Reprod Genet 2005;22:167-71
  12. Jiang ST, Kuang YP. Research progresses of the assisted reproductive techniques for hypogonadotropic hypogonadism patients. Shanghai Dier Yike Daxue Xuebao Bianji Shi 2017;37:128-33
  13. Kuroda K, Ezoe K, Kato K, Yabuuchi A, Segawa T, Kobayashi T, et al. Infertility treatment strategy involving combined freezeall embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism. J Obstet Gynaecol Res 2018